Drugs Home > Canikinumab

Were you looking for information about Canakinumab? Canikinumab is a common misspelling of canakinumab.
If you have certain rare genetic conditions called cryopyrin-associated periodic syndromes (CAPS), your healthcare provider may prescribe canakinumab (Ilaris®). This drug is used to help reduce inflammation that can occur in people with these conditions. It is given as an injection just under the skin (subcutaneously) once every eight weeks. You may not be able to receive this drug if you have certain allergies or if you are taking certain medications, vitamins, or supplements.
(Click Canakinumab for more information about how this medication works and when and how it is given, as well as general safety precautions you should be aware of before beginning treatment. You can also click any of the links in the box to the right for specific information.)
Written by/reviewed by:
Last reviewed by: Kristi Monson, PharmD;
Last updated/reviewed:
List of references (click here):
Other Articles in This eMedTV Presentation

Topics & Medications


Related Channels

eMedTV Links
Copyright © 2006-2020 Clinaero, Inc.

eMedTV serves only as an informational resource. This site does not dispense medical advice or advice of any kind. Site users seeking medical advice about their specific situation should consult with their own physician. Click Terms of Use for more information.

This site complies with the HONcode standard for trustworthy health information:
verify here.